다발경화증과 시신경척수염범주질환의 감별진단

키워드

참고문헌 (51)

1. Lennon VA, "A serum autoantibody marker of neuromyelitis optica:distinction from multiple sclerosis", Lancet, 364, pp.2106~2112 (2004)
2. Wingerchuk DM, "Revised diagnostic criteria for neuromyelitis optica", Neurology, 66, pp.1485~1489 (2006)
3. Wingerchuk DM, "The spectrum of neuromyelitis optica", Lancet Neurol, 6, pp.805~815 (2007)
4. Pugliatti M, "The epidemiology of multiple sclerosis in Europe", Eur J Neurol, 13, pp.700~722 (2006)
5. Wingerchuk DM, "Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies", Mayo Clin Proc, 89, pp.225~240 (2014)
6. Compston A, "Genetic epidemiology of multiple sclerosis", J Neurol Neurosurg Psychiatry, 62, pp.553~561 (1997)
7. Kim NH, "Prevalence of multiple sclerosis in Korea", Neurology, 75, pp.1432~1438 (2010)
8. Wingerchuk DM, "The clinical course of neuromyelitis optica (Devic's syndrome)", Neurology, 53, pp.1107~1114 (1999)
9. Pandit L, "Demographic and clinical features of neuromyelitis optica: A review", Mult Scler, 21, pp.845~853 (2015)
10. Pittock SJ, "Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later", Ann N Y Acad Sci, 1366, pp.20~39 (2016)
11. Siritho S, "AQP4 antibody-positive Thai cases: clinical features and diagnostic problems", Neurology, 77, pp.827~834 (2011)
12. Kim SM, "Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status", BMC Neurol, 14, pp.93~ (2014)
13. Etemadifar M, "Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis", Mult Scler Int, 2015, pp.174720~ (2015)
14. Poser CM, "New diagnostic criteria for multiple sclerosis: guidelines for research protocols", Ann Neurol, 13, pp.227~231 (1983)
15. McDonald WI, "Recommended diagnostic criteria for multiple sclerosis:guidelines from the International Panel on the diagnosis of multiple sclerosis", Ann Neurol, 50, pp.121~127 (2001)
16. Polman CH, "Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"", Ann Neurol, 58, pp.840~846 (2005)
17. Kappos L, "Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes", Neurology, 67, pp.1242~1249 (2006)
18. Beck RW, "The Optic Neuritis Treatment Trial", Arch ophthalmol, 106, pp.1051~1053 (1988)
19. Comi G, "Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial", Lancet, 374, pp.1503~1511 (2009)
20. Montalban X, "MRI criteria for MS in patients with clinically isolated syndromes", Neurology, 74, pp.427~434 (2010)
21. Lennon VA, "IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel", J Exp Med, 202, pp.473~477 (2005)
22. Kim W, "Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity", Mult Scler, 76, pp.1229~1236 (2010)
23. Kim W, "Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder", Mult Scler, 17, pp.1107~1112 (2011)
24. Wingerchuk DM, "International consensus diagnostic criteria for neuromyelitis optica spectrum disorders", Neurology, 85, pp.177~189 (2015)
25. Kim HJ, "MRI characteristics of neuromyelitis optica spectrum disorder: an international update", Neurology, 84, pp.1165~1173 (2015)
26. Popescu BF, "Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications", Neurology, 76, pp.1229~1237 (2011)
27. Weinshenker BG, "Neuromyelitis optica IgG predicts relapse after lon-gitudinally extensive transverse myelitis", Ann Neurol, 59, pp.566~569 (2006)
28. Misu T, "Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica", Neurology, 65, pp.1479~1482 (2005)
29. Takahashi T, "Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations", J Neurol Neurosurg Psychiatry, 79, pp.1075~1078 (2008)
30. Tackley G, "Magnetic resonance imaging in neuromyelitis optica", Mult Scler, 20, pp.1153~1164 (2014)
31. Flanagan EP, "Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders", JAMA Neurol, 72, pp.81~87 (2015)
32. Nakamura M, "Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study", J Neurol, 255, pp.163~170 (2008)
33. Pekcevik Y, "Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging", Mult Scler, 22, pp.302~311 (2015)
34. Yonezu T, "“Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis", Mult Scler, 20, pp.331~337 (2014)
35. Hyun JW, "Bright spotty lesions on the spinal cord: an additional MRI indicator of neuromyelitis optica spectrum disorder", J Neurol Neurosurg Psychiatry, 86, pp.1280~1282 (2015)
36. Kim SM, "Painful tonic spasm in neuromyelitis optica: incidence, diagnostic utility, and clinical characteristics", Arch Neurol, 69, pp.1026~1031 (2012)
37. Usmani N, "Association between paroxysmal tonic spasms and neuromyelitis optica", Arch Neurol, 69, pp.121~124 (2012)
38. Storoni M, "Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: a novel magnetic resonance imaging scoring system", J Neuroophthalmol, 33, pp.123~127 (2013)
39. Khanna S, "Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis", J Neuroophthalmol, 32, pp.216~220 (2012)
40. Fernandes DB, "Comparison of visual acuity and automated perimetry findings in patients with neuromyelitis optica or multiple sclerosis after single or multiple attacks of optic neuritis", J Neuroophthalmol, 32, pp.102~106 (2012)
41. Kremer S, "Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder", JAMA Neurol, 72, pp.815~822 (2015)
42. Ratchford JN, "Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies", Neurology, 73, pp.302~308 (2009)
43. Kim W, "Brain abnormalities in neuromyelitis optica spectrum disorder", Mult Scler Int, 2012, pp.735486~ (2012)
44. Huh SY, "The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders", Mult Scler, 20, pp.695~704 (2014)
45. Matthews L, "Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution", Neurology, 80, pp.1330~1337 (2013)
46. Sinnecker T, "Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis", Neurology, 79, pp.708~714 (2012)
47. Quinn MP, "Venocentric Lesions: An MRI Marker of MS", Front Neurol, 4, pp.98~ (2013)
48. Ciccarelli O, "Low myo-inositol indicating astrocytic damage in a case series of neuromyelitis optica", Ann Neurol, 74, pp.301~305 (2013)
49. Jarius S, "Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures", J Neurol Sci, 306, pp.82~90 (2011)
50. Dobson R, "Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes:a meta-analysis of prevalence, prognosis and effect of latitude", J Neurol Neurosurg Psychiatry, 84, pp.909~914 (2013)
51. Bergamaschi R, "Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations", Mult Scler, 10, pp.2~4 (2004)

관련 논문AI추천